Where does Sejong Pharmatech Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sejong Pharmatech Co., Ltd. ranks #42,875 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sejong Pharmatech Co., Ltd. hold?

Sejong Pharmatech Co., Ltd. holds 6 US utility patents granted between 2015 and 2021, spanning 4 technology areas.

What is Sejong Pharmatech Co., Ltd.'s Innovation Score?

Sejong Pharmatech Co., Ltd. has an Innovation Score of 16.8 out of 100 (4th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sejong Pharmatech Co., Ltd. focus on?

Sejong Pharmatech Co., Ltd.'s top technology area is B30B (Presses IN General) with 3 patents. Grants appear in 4 CPC subclasses total.

Is Sejong Pharmatech Co., Ltd.'s patent grant rate increasing or decreasing?

Sejong Pharmatech Co., Ltd.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sejong Pharmatech Co., Ltd.'s patents?

Sejong Pharmatech Co., Ltd.'s patents average 5.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sejong Pharmatech Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sejong Pharmatech Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B30B (Presses IN General).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sejong ranks #42,875 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.

#42,875
of 49,997 US assignees by volume: 4th percentile
by Innovation Score (16.8/100): 5.0
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42875 · Foreign Corporation #42,875 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #42,875/49,997
PHOTO-FINISH Seek XR
CPC-NARROW B30B · 4 areas
INNOV-LOW 16.8/100
CLAIMS-SPARSE 5.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Seek XR, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Sejong Pharmatech · this assignee

17
3D Lighting… · lowest

7

What this shows Sejong's Innovation Score is 16.8/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Sejong's grants concentrate

Sejong Pharmatech Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 50% of grants classified under B30B (Presses IN General). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Sejong sits between Seek XR, Inc. and Sellars Absorbent Materials, Inc..

Seek XR

6
SEE—Soluções Ener…

6
Segton Advanced T…

6
Seiko Clock

6
Sejong University…

6
Selc Ireland

6
Select Star

6
Sellars Absorbent…

6
Sejong Pharmatech ◀

6

What this shows Sejong holds 6 patents at rank #42,783, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sejong

By rank, the assignees closest to #42,783 in granted patent volume.

Leaders in B30B (Presses IN General)

Other assignees with the most granted patents in Sejong's primary technology class.

Sejong's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

17 4th percentile higher than 4% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sejong Pharmatech Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2016	2	33.3%
2019	1	16.7%
2020	1	16.7%
2021	1	16.7%

Which technologies does Sejong Pharmatech Co., Ltd. patent most?

B30B - Presses IN General 3

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 1

E06B - Fixed OR Movable Closures FOR Openings IN Buildings, Vehicles, Fences OR Like Enclosures IN General, e.g. Doors, Windows, Blinds, Gates 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#42,875

of 49,997 tracked assignees

Innovation Score

16.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sejong Pharmatech Co., Ltd.'s patent record in context - here's where to go next.

Sejong Pharmatech Co., Ltd.'s lead technology class is B30B (Presses IN General), 50% of its portfolio - see every assignee active in that class. Explore B30B
Ranked #42,875 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sejong Pharmatech Co., Ltd. against Seek XR, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 16.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.